A growing body of evidence suggests that millions of elderly Americans may be left exposed by a regulatory system that rarely uses its strongest enforcement tools.

A new analysis by researchers at Brown University has raised serious concerns about how the U.S. government oversees private Medicare Advantage plans, accusing regulators of being “asleep at the wheel” while insurance giants repeatedly violate rules meant to protect seniors.

The report paints a troubling picture. More than 30 million older Americans rely on private Medicare plans for their healthcare coverage. Yet, despite having sweeping powers to penalise or even shut down underperforming insurers, federal regulators have almost never exercised these options.

At the heart of the criticism is a stark statistic: while nearly 90% of Medicare Advantage plans have been cited for some form of misconduct—ranging from misleading advertisements to delaying or denying necessary care—less than 1% have faced the ultimate penalty of termination. Experts say this gap reflects not just leniency, but a systemic failure to enforce accountability.

“The government has the equivalent of a ‘death penalty’ for plans that repeatedly break the rules,” the report notes, referring to its authority to suspend or terminate contracts. “But in practice, that power is almost never used.”

Instead, most violations are met with relatively mild consequences such as warning letters or small financial penalties—costs that large insurance companies can easily absorb as part of doing business.

This lack of deterrence appears to be fueling a cycle of repeat offenses. According to the analysis, nearly one in five plans flagged for violations are repeat offenders. Researchers argue that insurers are making calculated decisions, knowing that the likelihood of facing serious punishment is extremely low.

The implications for patients are significant. Delays in care approvals, denials of coverage, and confusing or misleading marketing can directly impact health outcomes, especially for older adults who often depend on timely access to treatment.

Critics say the problem is not a lack of rules, but a failure of enforcement. Over the years, Medicare Advantage has grown rapidly, driven by government incentives and aggressive expansion by private insurers. However, oversight mechanisms have not kept pace with this growth.

There is also concern about regulatory hesitation. Some experts suggest that the government may be reluctant to crack down too hard on major insurers for fear of disrupting coverage for millions of beneficiaries or triggering political backlash.

But public health advocates argue that this cautious approach is backfiring. By failing to act decisively against bad actors, regulators may be undermining trust in the system and allowing harmful practices to continue unchecked.

The report calls for a more assertive enforcement strategy, including greater use of contract terminations for repeat violators and stricter penalties that genuinely deter misconduct.

As the Medicare Advantage program continues to expand, the question now is whether regulators will step up—or remain, as critics put it, asleep at the wheel.